Research suggests that using immunotherapy drugs before surgery can improve outcomes for melanoma patients. Some studies indicate that lower doses of immunotherapy can be particularly effective, with reports of improved response rates. The specifics of the treatment and its effects are still being explored, with various findings and implications for melanoma care being discussed.